PMC:7253482 / 18-400
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 1-12 | Species | denotes | coronavirus | Tax:11118 |
3 | 13-19 | Chemical | denotes | glycan | MESH:D011134 |
25 | 115-168 | Species | denotes | Middle East respiratory syndrome (MERS) coronaviruses | Tax:1335626 |
26 | 170-174 | Species | denotes | CoVs | Tax:11118 |
33 | 349-354 | Gene | denotes | spike | Gene:43740568 |
39 | 70-103 | Disease | denotes | Severe acute respiratory syndrome | MESH:D045169 |
40 | 105-109 | Disease | denotes | SARS | MESH:D045169 |
41 | 180-188 | Disease | denotes | zoonotic | MESH:D015047 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 359-371 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 70-103 | Disease | denotes | Severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 105-109 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 268-275 | http://purl.obolibrary.org/obo/CLO_0009985 | denotes | focuses |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 359-371 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 189-198 | http://purl.obolibrary.org/obo/IDO_0000528 | denotes | pathogens |
T2 | 320-343 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 328-343 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sample-Enju
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 1-12 | NN | denotes | coronavirus |
T3 | 13-19 | NN | denotes | glycan |
T4 | 20-27 | NNS | denotes | shields |
T5 | 28-35 | IN | denotes | despite |
T6 | 36-45 | JJ | denotes | extensive |
T7 | 46-59 | NN | denotes | glycosylation |
T8 | 61-69 | NN | denotes | Abstract |
T9 | 70-76 | JJ | denotes | Severe |
T10 | 77-82 | JJ | denotes | acute |
T11 | 83-94 | JJ | denotes | respiratory |
T12 | 95-103 | NN | denotes | syndrome |
T13 | 104-105 | -LRB- | denotes | ( |
T14 | 105-109 | NN | denotes | SARS |
T15 | 109-110 | -RRB- | denotes | ) |
T16 | 111-114 | CC | denotes | and |
T17 | 115-121 | NNP | denotes | Middle |
T18 | 122-126 | NNP | denotes | East |
T19 | 127-138 | JJ | denotes | respiratory |
T20 | 139-147 | NN | denotes | syndrome |
T21 | 148-149 | -LRB- | denotes | ( |
T22 | 149-153 | NNS | denotes | MERS |
T23 | 153-154 | -RRB- | denotes | ) |
T24 | 155-168 | NNS | denotes | coronaviruses |
T25 | 169-170 | -LRB- | denotes | ( |
T26 | 170-174 | NNS | denotes | CoVs |
T27 | 174-175 | -RRB- | denotes | ) |
T28 | 176-179 | VBP | denotes | are |
T29 | 180-188 | JJ | denotes | zoonotic |
T30 | 189-198 | NNS | denotes | pathogens |
T31 | 199-203 | IN | denotes | with |
T32 | 204-208 | JJ | denotes | high |
T33 | 209-217 | NN | denotes | fatality |
T34 | 218-223 | NNS | denotes | rates |
T35 | 224-227 | CC | denotes | and |
T36 | 228-236 | JJ | denotes | pandemic |
T37 | 237-246 | NN | denotes | potential |
T38 | 248-255 | NN | denotes | Vaccine |
T39 | 256-267 | NN | denotes | development |
T40 | 268-275 | VBZ | denotes | focuses |
T41 | 276-278 | IN | denotes | on |
T42 | 279-282 | DT | denotes | the |
T43 | 283-292 | JJ | denotes | principal |
T44 | 293-299 | NN | denotes | target |
T45 | 300-302 | IN | denotes | of |
T46 | 303-306 | DT | denotes | the |
T47 | 307-319 | VBG | denotes | neutralizing |
T48 | 320-327 | JJ | denotes | humoral |
T49 | 328-334 | JJ | denotes | immune |
T50 | 335-343 | NN | denotes | response |
T51 | 343-344 | -COMMA- | denotes | , |
T52 | 345-348 | DT | denotes | the |
T53 | 349-354 | NN | denotes | spike |
T54 | 355-356 | -LRB- | denotes | ( |
T55 | 356-357 | NN | denotes | S |
T56 | 357-358 | -RRB- | denotes | ) |
T57 | 359-371 | NN | denotes | glycoprotein |
R6 | T7 | T6 | arg1Of | glycosylation,extensive |
R7 | T12 | T9 | arg1Of | syndrome,Severe |
R8 | T12 | T10 | arg1Of | syndrome,acute |
R9 | T12 | T11 | arg1Of | syndrome,respiratory |
R2 | T4 | T2 | arg1Of | shields,coronavirus |
R3 | T4 | T3 | arg1Of | shields,glycan |
R5 | T7 | T5 | arg2Of | glycosylation,despite |
R10 | T12 | T13 | arg1Of | syndrome,( |
R11 | T14 | T13 | arg2Of | SARS,( |
R12 | T15 | T13 | arg3Of | ),( |
R13 | T12 | T16 | arg1Of | syndrome,and |
R14 | T20 | T16 | arg2Of | syndrome,and |
R15 | T18 | T17 | arg1Of | East,Middle |
R16 | T20 | T18 | arg1Of | syndrome,East |
R17 | T20 | T19 | arg1Of | syndrome,respiratory |
R18 | T20 | T21 | arg1Of | syndrome,( |
R19 | T22 | T21 | arg2Of | MERS,( |
R20 | T23 | T21 | arg3Of | ),( |
R21 | T28 | T24 | arg1Of | are,coronaviruses |
R22 | T24 | T25 | arg1Of | coronaviruses,( |
R23 | T26 | T25 | arg2Of | CoVs,( |
R24 | T27 | T25 | arg3Of | ),( |
R25 | T16 | T28 | arg1Of | and,are |
R26 | T30 | T28 | arg2Of | pathogens,are |
R27 | T30 | T29 | arg1Of | pathogens,zoonotic |
R28 | T30 | T31 | arg1Of | pathogens,with |
R29 | T35 | T31 | arg2Of | and,with |
R30 | T34 | T32 | arg1Of | rates,high |
R31 | T34 | T33 | arg1Of | rates,fatality |
R32 | T34 | T35 | arg1Of | rates,and |
R33 | T37 | T35 | arg2Of | potential,and |
R34 | T37 | T36 | arg1Of | potential,pandemic |
R35 | T39 | T38 | arg1Of | development,Vaccine |
R36 | T39 | T40 | arg1Of | development,focuses |
R37 | T40 | T41 | arg1Of | focuses,on |
R38 | T44 | T41 | arg2Of | target,on |
R39 | T44 | T42 | arg1Of | target,the |
R40 | T44 | T43 | arg1Of | target,principal |
R41 | T44 | T45 | arg1Of | target,of |
R42 | T50 | T45 | arg2Of | response,of |
R43 | T50 | T46 | arg1Of | response,the |
R44 | T50 | T47 | arg1Of | response,neutralizing |
R45 | T50 | T48 | arg1Of | response,humoral |
R46 | T50 | T49 | arg1Of | response,immune |
R47 | T50 | T51 | arg1Of | response,"," |
R48 | T57 | T51 | arg2Of | glycoprotein,"," |
R49 | T57 | T52 | arg1Of | glycoprotein,the |
R50 | T57 | T53 | arg1Of | glycoprotein,spike |
R51 | T53 | T54 | arg1Of | spike,( |
R52 | T55 | T54 | arg2Of | S,( |
R53 | T56 | T54 | arg3Of | ),( |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 359-371 | Body_part | denotes | glycoprotein | http://purl.org/sig/ont/fma/fma62925 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 359-371 | Chemical | denotes | glycoprotein | http://purl.obolibrary.org/obo/CHEBI_17089 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T1 | 70-103 | Species | denotes | Severe acute respiratory syndrome | NCBItxid:694009 |
T2 | 105-109 | Species | denotes | SARS | NCBItxid:694009 |
T3 | 149-153 | Species | denotes | MERS | NCBItxid:1335626 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 61-69 | Sentence | denotes | Abstract |
T3 | 70-247 | Sentence | denotes | Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. |
T4 | 248-372 | Sentence | denotes | Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein. |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 70-103 | Disease | denotes | Severe acute respiratory syndrome | http://purl.obolibrary.org/obo/MONDO_0005091 |
T2 | 105-109 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
2 | 1-12 | Species | denotes | coronavirus | Tax:11118 |
3 | 13-19 | Chemical | denotes | glycan | MESH:D011134 |
39 | 70-103 | Disease | denotes | Severe acute respiratory syndrome | MESH:D045169 |
40 | 105-109 | Disease | denotes | SARS | MESH:D045169 |
25 | 115-168 | Species | denotes | Middle East respiratory syndrome (MERS) coronaviruses | Tax:1335626 |
68 | 155-168 | Species | denotes | coronaviruses | Tax:11118 |
69 | 170-174 | Species | denotes | CoVs | Tax:11118 |
26 | 170-174 | Species | denotes | CoVs | Tax:11118 |
41 | 180-188 | Disease | denotes | zoonotic | MESH:D015047 |
33 | 349-354 | Gene | denotes | spike | Gene:43740568 |
LitCovid-sample-UniProt
Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
---|---|---|---|---|---|
T1 | 355-371 | Protein | denotes | (S) glycoprotein | https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1 |
LitCovid-sample-PD-GO-BP-0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 46-59 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T2 | 320-343 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 328-343 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sample-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 46-59 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T2 | 320-343 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 328-343 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 46-59 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
T2 | 320-343 | http://purl.obolibrary.org/obo/GO_0006959 | denotes | humoral immune response |
T3 | 328-343 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune response |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 61-69 | Sentence | denotes | Abstract |
T3 | 70-247 | Sentence | denotes | Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) are zoonotic pathogens with high fatality rates and pandemic potential. |
T4 | 248-372 | Sentence | denotes | Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein. |